Navigation Links
Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Date:11/7/2012

cerMore than one million people worldwide are diagnosed with breast cancer globally every year. (1)  The chance of developing invasive breast cancer at some time in a woman's life is a little less than one in eight (12%).  There are approximately 200,000 new cases of breast cancer in the United States and 430,000 in Europe each year. (2)  Metastatic breast cancer refers to cancer that has spread from the breast to distant sites in the body. 

Anthracyclines and taxanes (AT) are the most active and widely used chemotherapeutic agents for breast cancer, but the increased use of these agents at an early stage of disease often renders tumors resistant to these drugs by the time the disease recurs, thereby reducing the number of treatment options for metastatic disease. Drugs used to treat patients who progress following AT treatment can have response rates of 20-30%; however, resistance develops rapidly and new agents with different mechanisms of action, such as topoisomerase I inhibitors, are needed that have the potential to overcome the problem of drug resistance to prior therapies. (3)  There are currently no FDA-approved topoisomerase I inhibitors to treat breast cancer.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which is being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid.  NKTR-181, a novel mu-opioid analgesic can
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
3. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
10. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
11. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, for the ... U.S. and European rheumatologists cite a therapy,s induction ... most influences their prescribing decisions. Over 60 percent ... respectively, rank the percentage of patients achieving remission ...
(Date:6/19/2013)... -- BD Biosciences, a segment of BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... of high-performance research flow cytometers. The BD ... most compact footprint in its class at just 30" x ... (76.2 cm). Recognizing that space is a valuable commodity in ...
(Date:6/19/2013)... N.J. , June 19, 2013 /PRNewswire-iReach/ ... Pharma, a new specialty pharmaceutical company dedicated ... of innovative injectable and sustained release drug ... unmet medical needs, today announced the acquisition ... Linker Technology®) platform and associated product pipeline. ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... TARPON SPRINGS, Fla., May 7 Methadone medication ... to menopausal levels, even in women less than ... methadone, can cause depression, anxiety, fatigue, weight gain, ... flashes, and increased risk for heart attack and ...
... May 7 In letters to Senate Special Committee ... Committee Ranking Member Charles Grassley (R-IA), Johnson & Johnson ... Act of 2009 (S. 301). The company also committed ... its U.S. pharmaceutical, medical device and diagnostics companies."We are ...
Cached Medicine Technology:Methadone Frequently Causes Menopausal Symptoms in Young Women 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 3
(Date:6/19/2013)... Go Classy Tours has the reputation for specializing in ... Years. These resorts, draw many clients from around the ... nude hot tubs. Grand Lido Negril was a favorite ... the resort to a Breezes and dis-continued the "Lido" luxury ... fell off dramatically. "Groups just went to other nude ...
(Date:6/19/2013)... June 19, 2013 According to ... clinics, excessive sun exposure is perhaps the biggest ... cancer, but that is just one of many ... of skin cancer. Other risk factors include:, ...     Radiation treatment ,     Heredity may play a ...
(Date:6/19/2013)... Scottsdale, AZ (PRWEB) June 19, 2013 Are ... could be losing clients to the competition. , Social ... sales at your massage practice. , Included in your ... into an effective tool in building awareness and revenue for ... now over 5.5 million Twitter users worldwide. Many of these ...
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up ... by top skin care manufacturer EMINENCE to meet customer ... minerals and active organic ingredients to promote actual change ... beauty products offer. For this reason it’s not hard ... "I like products that do what they say they ...
(Date:6/19/2013)... Sylmar, CA (PRWEB) June 19, 2013 ... to its website located at http://www.kleritec.com . In ... and creative, pre-selected, art and activities packages for pre-school ... educational products as a method to aid teachers across ... busy and engaged in learning. , Included in the ...
Breaking Medicine News(10 mins):Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:Kleritec Announces Addition of Educational Products. 2
... , , FRIENDSWOOD, Texas, ... which develops, manages and owns faith-based senior living facilities, today announced ... Inc. for the development of a new senior living facility in ... Heights , an 82-unit, $10 million senior living facility, should be ...
... , COLORADO SPRINGS, Colo., July 28 University ... Military Tuition Grant for university students serving on active duty in ... National Guard and reserves, who pursue a master,s or doctoral degree ... Active Duty Military Tuition Grant offers the following benefits, effective with ...
... , , SAN DIEGO, ... San Diego based medical device company, today announced that F. ... its Board of Directors. , , ... following graduation from San Diego State University in 1961. He ...
... , BATON ROUGE, La. and ALEXANDRIA, Va., ... Rx Access announced today the launch of the Together Rx Access(R) ... immediate and meaningful savings on prescription medicines and products right at ... collaboration will use existing State outreach channels to identify additional uninsured ...
... , BEDFORD, Mass., July 28 ... (Nasdaq: HOLX ), a leading developer, manufacturer and ... dedicated to serving the healthcare needs of women, today announced ... for women suffering from excessive menstrual bleeding--has passed the one ...
... , , , ... (pronounced ah-sigh-EE) has become America,s new super fruit of choice due ... of acai juice can contain a large amount of natural sugar, ... Healthy Balance line of Fit for Your Lifestyle(TM) ...
Cached Medicine News:Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 4Health News:University of the Rockies Introduces Military Tuition Grant 2Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 2Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 3Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 4Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 2Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 3Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 4Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 2Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 3Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 4Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 5Health News:Old Orchard Brands Introduces Low-Sugar Acai Juice Blend 2
... thermocycler with unique High Temperature ... fastest available heating and cooling ... High Pressure Lid for automated ... Includes motorized lid for automated ...
... TC-512 has a graphical touch screen display ... at the "touch of a screen." ... gradient, Touch Screen, Graphical Display, Memory Cards, ... Block Format, Intuitive Programmin, Free Instrument Software ...
... 32 Thermal Block has a compact design for ... temperatures rapidly, and can handle up to 32 samples ... so there is no need to add mineral oil ... 100 programs can be stored, and up to 15 ...
PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
Medicine Products: